You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2024

AbstractFullPdf
Dec 2019220
Jan 202015155
Feb 202036362
Mar 202034346
Apr 2020616113
May 2020646410
Jun 202044446
Jul 202035357
Aug 202056569
Sep 2020525210
Oct 2020838314
Nov 2020505018
Dec 2020505014
Jan 202114814812
Feb 2021828214
Mar 202189897
Apr 2021696917
May 2021737310
Jun 2021777713
Jul 2021929214
Aug 2021939321
Sep 2021838318
Oct 2021999923
Nov 202110510511
Dec 202111611915
Jan 202210311821
Feb 2022859119
Mar 202221321915
Apr 202211712326
May 202211712518
Jun 202216517833
Jul 202216817722
Aug 202214315427
Sep 202213314520
Oct 202213113925
Nov 202221522040
Dec 202212212221
Jan 202316716924
Feb 202316116222
Mar 202314915125
Apr 202313013422
May 2023979722
Jun 202311011224
Jul 202310210211
Aug 2023899022
Sep 202310610714
Oct 202320020021
Nov 202327827926
Dec 202314814956
Jan 202411011155
Feb 202414914945
Mar 202415715792
Apr 202414114253
May 202411411848
Jun 202412112453
Jul 202410510847
Aug 202410911137
Sep 202411411454
Total627764081349